B. Rubin

发表

Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study

W. Ondo, R. Hauser, S. Isaacson, 2021, PLoS ONE.

A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis

M. Kaiser-Kupfer, W. Gahl, G. Reed, 2003, The British journal of ophthalmology.

A comparison of zopiclone and propiomazine as hypnotics in outpatients: a multicentre, double-blind, randomized, parallel-group comparison of zopiclone and propiomazine in insomniacs.

O. Dehlin, C. Bengtsson, B. Rubin, 1997, Current medical research and opinion.

Double-blind comparison of zopiclone and flunitrazepam in elderly insomniacs with special focus on residual effects.

Å. Rundgren, O. Dehlin, B. Rubin, 1995, Current medical research and opinion.

The effect of systemic metronidazole after non-surgical treatment in moderate and advanced periodontitis in young adults.

S. Wikner, P. Söder, P. Engström, 1990, Journal of periodontology.

A double-blind comparison of oral ketoprofen 'controlled release' and indomethacin suppository in the treatment of rheumatoid arthritis with special regard to morning stiffness and pain on awakening.

I. Leden, P. Uddenfeldt, B. Rubin, 1993, Current medical research and opinion.

Comparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the knee.

R. Trapp, F. Mcmahon, A. Weaver, 1995, Clinical therapeutics.

The efficacy, tolerability, and safety of 1200 mg/d of oxaprozin and 1500 mg/d of nabumetone in the treatment of patients with osteoarthritis of the knee.

J. Ganju, R. Trapp, F. Mcmahon, 1996, Clinical therapeutics.

Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study

W. Ondo, R. Hauser, S. Isaacson, 2021, PloS one.